Effects of methamphetamine on the cerebellar cortex: A preliminary study

Annals of the New York Academy of Sciences

Volumn 1074, Issue , 2006, Pages 149-153

  Ferrucci, Michela ^a   Busceti, Carla L ^b   Falleni, Alessandra ^a   Giorgi, Filippo S ^a   Ruggieri, Stefano ^b,c   Fornai, Francesco ^a,b  

^a UNIVERSITY OF PISA   (Italy)

^b IRCCS NEUROMED   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Cerebellum; Tyrosine hydroxylase; Western blot

Indexed keywords

BRAIN MONOAMINE; METHAMPHETAMINE; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BASAL GANGLION; BRAIN FUNCTION; CATECHOLAMINE RELEASE; CELL COMPARTMENTALIZATION; CEREBELLUM CORTEX; CONFERENCE PAPER; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG ABUSE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MOTOR ACTIVITY; MOTOR CONTROL; MOUSE; NERVE ENDING; NONHUMAN; PROTEIN EXPRESSION; WESTERN BLOTTING;

EID: 33749582559     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1369.014     Document Type: Conference Paper

References (16)

1. RICAURTE, G.A. et al. 1982. Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain. Brain Res. 235: 93-103.
2. WOOLVERTON, W.L. et al. 1989. Long-term effects of chronic methamphetamine administration in rhesus monkeys. Brain Res.486: 73-78.
3. O'CALLAGHAN, J.P. & D.B. MILLER. 1994. Neurotoxicity profiles of substituted amphetamines in the C57BL/6J mouse. J. Pharmacol. Exp. Ther. 270: 741-751.
4. FORNAI, F. et al. 1995. Norepinephrine loss exacerbates methamphetamine-induced striatal dopamine depletion in mice. Eur. J. Pharmacol. 283: 99-102.
5. HANSON, G.R. et al. 2004. The methamphetamine experience: a NIDA partnership. Neuropharmacology 47: 92-100.
6. KOGAN, F.J. et al. 1976. Influence of methamphetamine on nigral and striatal tyrosine hydroxylase activity and on striatal dopamine levels. Eur. J. Pharmacol. 36: 363-371.
7. PAXINOS, G. 1995. The Rat Nervous System, 2nd ed. Academic Press, Inc. San Diego, CA.
8. PAXINOS, G. & J.K. MAI. 2004. The Human Nervous System, 2nd ed. Elsevier Academic Press. New York.
9. PANAGOPOULOS, N.T. et al. 1991. Dopaminergic innervation and binding in the rat cerebellum. Neurosci. Lett. 130: 208-212.
10. MELCHITZKY, D.S. & D.A. LEWIS. 2000. Tyrosine hydroxylase- and dopamine transporter-immunoreactive axons in the primate cerebellum. Neuropsychopharmacology 22: 466-472.
11. FORNAI, F. et al. 2004. Methamphetamine produces neuronal inclusions in the nigrostriatal system and in PC12 cells. J. Neurochem. 88: 114-123.
12. HAMAMURA, M. et al. 1999. Differential decreases in c-fos and aldolase C mRNA expression in the rat cerebellum after repeated administration of methamphetamine. Mol. Brain Res. 64: 119-131.
13. NUMACHI, Y. et al. 2000. Two inbred strains of rats, Fischer 344 and Lewis, showed differential behavior and brain expression of corticosterone receptor mRNA induced by methamphetamine. Ann. N. Y. Acad. Sci. 914: 33-45.
14. JENG, C.H. & Y. WANG. 1998. Methamphetamine modulates GABA-induced electrophysiological depression by alternating noradrenergic actions in cerebellar Purkinje neurons. Psychopharmacology (Berl.) 136: 132-138.
15. WANG, Y. et al. 2000. Chronic methamphetamine exposure decreases high affinity uptake function in norepinephrine afferents in the cerebellar cortex: an electrophysiological and electrochemical study. Psychopharmacology (Berl.) 39: 2112-2123.
16. SAWADA, K. et al. 1999. Abnormal expression of tyrosine hydroxylase immunoreactivity in cerebellar cortex of ataxic mutant mice. Brain Res. 829: 107-112.